Amesite Inc

Amesite Inc (AMST) Stock Analysis

$0.515

-0.021 (-4.15%)At close

Loading chart…
High
0.537
Open
0.537
VWAP
0.52
Volume
24.47K
Mkt Cap
7.04M
Low
0.515
Amount
12.79K
EV/EBITDA, TTM
0.00

Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.

amesite.com

AI analysis of Amesite Inc (AMST)

Sell

Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.

Valuation Metrics

The current forward P/E ratio for Amesite Inc (AMST) is 0.00, compared to its 5-year average forward P/E of -2.94.

Forward P/E

Fair
5Y Average P/E
-2.94
Current P/E
0.00
Overvalued
5.76
Undervalued
-11.63

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-3.91
Current EV/EBITDA
0.00
Overvalued
17.01
Undervalued
-24.83

Forward P/S

Fair
5Y Average P/S
1.59
Current P/S
0.00
Overvalued
4.22
Undervalued
-1.04

Events Timeline

2026-09-24 (ET)

07:00:00

Amesite Launches New Sales Model, NurseMagic Enterprise Priced at $1,099 per Month

2026-05-12 (ET)

17:30:00

Amesite Files Prospectus for Resale of 4.84M Shares

2026-04-27 (ET)

12:40:00

Amesite Issues 696,866 Shares at $1.435 Each

11:20:00

X-energy and Yesway Show Strong Debut Performance

09:40:00

Amesite Files for Withdrawal of S-1 Registration Statement

News

AMST FAQ — answered by Alphio AI

Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading